At this month’s Food and Nutrition Conference and Expo in Nashville, one buzzword dominated conversations – GLP-1 medications. From protein-packed bars, portion-controlled snacks to prepared meals, brands are racing to market foods for a rapidly growing segment, those taking popular weight loss drugs like Wegovy and Ozempic.

Last year, 12% of US adults tried a GLP-1, with survey data suggesting that number will double in 2025, to 1 in 4. For an industry built on appetites, brands are quickly trying to respond to what this means for consumers.

GLP-1s are Changing Food Behavior

GLP-1 drugs work by suppressing appetite and slowing digestion. Their rise is reshaping what—and how much—consumers buy at the grocery store.

Among GLP-1 users, consumption of snacks, sugar drinks, and desserts ha

See Full Page